Noble Metal 주식 가격. NMG.H - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
캐나다
TSXV
Noble Metal Group Incorporated (NMG.H) 시세

Noble Metal Group Incorporated (NMG.H)

0.005

0.00

(0.00%)

마감 27 9월 5:00AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

가격

0.005

매수가

0.005

매도가

0.005

거래량

-

0.00 일간 변동폭 0.00

0.00 52주 범위 0.00

market_cap

전일 종가

0.005

개장가

-

최근 거래 시간

마지막 거래 시간

재정 규모

-

VWAP

-

평균 볼륨(3m)

-

발행 주식

126,106,000

배당수익률

-

주가수익률

0.00

주당순이익(EPS)

-0

매출

-

순이익

-268k

섹터

Gold Ores

산업

Gold Ores

본부

Chilliwack, British Columbia, Can

설립됨

-

Noble Metal Group Incorporated is listed in the Gold Ores sector of the TSX 벤처 거래소 with ticker NMG.H. The last closing price for Noble Metal was $0.01. Over the last year, Noble Metal shares have traded in a share price range of $ 0.00 to $ 0.00.

Noble Metal currently has 126,106,000 shares in issue. The market capitalisation of Noble Metal is $630,530 . Noble Metal has a price to earnings ratio (PE ratio) of 0.00.

No news to show yet.

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
AAAAAuralite Investments Inc	$ 0.265 (0.00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0.05 (0.00%)	0
AAAlba Minerals Ltd	$ 0.03 (0.00%)	0
A.HArmor Minerals Inc	$ 0.40 (0.00%)	0
AArmor Minerals Inc	$ 0.45 (0.00%)	0
AAAAAuralite Investments Inc	$ 0.265 (0.00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0.05 (0.00%)	0
AAAlba Minerals Ltd	$ 0.03 (0.00%)	0
A.HArmor Minerals Inc	$ 0.40 (0.00%)	0
AArmor Minerals Inc	$ 0.45 (0.00%)	0
AAAAAuralite Investments Inc	$ 0.265 (0.00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0.05 (0.00%)	0
AAAlba Minerals Ltd	$ 0.03 (0.00%)	0
A.HArmor Minerals Inc	$ 0.40 (0.00%)	0
AArmor Minerals Inc	$ 0.45 (0.00%)	0

Risk

This is awesome. Thanks TJ. Need a lot of patience.

nidan7500

nidan7500 4 분 전

georgejjiUS FDA approves Bristol Myers' schizophrenia drug

FDA approval for new type of schizophrenia treatment

ristol prices drug at $1,850 a month

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-bristol-myers-schizophrenia-dr

RobotDroid

RobotDroid 4 분 전

Another wrong opinion. Too funny how the cult looks at other companies data and thinks it applies to nwbo. It doesn't, no other compnay has the worst, inept mute mismanagement clown show in history.

Risk

TJ that’s better dream :)) OS dream big :))

Wingsjr

Wingsjr 5 분 전

Thx, brother. 👍

Golden Cross

Golden Cross 5 분 전

$XXII New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile
https://www.newsfilecorp.com/release/224193/22nd-Century-Announces-New-Branded-Products-Order-with-Customer-for-Southeast-Asi

GetSeriousOK

GetSeriousOK 6 분 전

Call her then.

And don't accept "we'll release a PR when it's appropriate" for an answer.

Personally, I wouldn't believe anything she told you over the phone, but that's just my experience with biotech CEO phone calls. Whatever she says, tell her "Put that in writing.

Golden Cross

Golden Cross 6 분 전

$XXII New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile
https://www.newsfilecorp.com/release/224193/22nd-Century-Announces-New-Branded-Products-Order-with-Customer-for-Southeast-Asi

weedtrader420

weedtrader420 6 분 전

XRP✊😎 Lynyrd Skynyrd SIMPLE MAN $1 TARGET

MFranny

MFranny 6 분 전

That's where, at the very least, Steven Walker should have been present. But he wasn't...

GetSeriousOK

GetSeriousOK 7 분 전

Sorry, the patents expired due to non-payment of maintenance fees.

"Extended to 2029" refers to the Patent Term Restoration (PTR) extension. IF Whelan had paid the maintenance fees, the patents would be active until 2029. Without that extension they would have expired in 2023, twenty

manibiotech

manibiotech 7 분 전

In that case they will have to take personal responsibility and be held accountable . Current strategy transfers 100% of responsibility and blame on someone else . So what’s the incentive to change ?

zj3001

zj3001 7 분 전

$RNAZ everyone so focused on a price per share, but no one ever talks about market cap. Imagine Transcode getting a $50-200m upfront payment to partner with Big Pharma. What do you think that makes the value of the company?

What if they get fda fast track approval?

It

Alexulf

Alexulf 8 분 전

We continue the climb up!

Strong news do the trick :-)

https://aitx.ai/

MetaMonster

MetaMonster 8 분 전

Ceo Mark White is in rehab for drug addiction

FeMike

FeMike 8 분 전

That's just a guess, and probably wrong.
You realize you are an absolute moron, right? 3 months ago after the ASM, when I said we hadn't gotten an RFI yet and were still in phase 1, you told me that was "100% not true". When i asked you to clarify, you said:
We are not in phase 1. Th

James56

James56 8 분 전

2020trader

2020trader 8 분 전

that would be a wasted call...lol

1vman

1vman 8 분 전

*****Wowzah🟥🟥🟥🟥 Power2theGMEshorters/brilliant, interest has faded big time here

ENOUGH SAID

arachnodude

arachnodude 9 분 전

Consider demand influences the rate at which they produce, but the capacity reflects what the facility is capable of producing under optimal conditions, regardless of how much is currently being ordered or sold.

kid70

kid70 9 분 전

Hopefully, we can beat yesterday volume. Lol

Deano361

Deano361 9 분 전

Now from 100 to 500m?

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관